Lit Matters 2: The Benefits and Harms of Screening for Depression and Suicidality

Depression screening has measurable primary-care benefit, but the evidence for suicide-risk screening remains thin and uncertain. In emergency medicine, a positive screen for severe depression or suicidality should trigger a fuller bedside assessment rather than confidence in the tool itself.

Screening for Depression and Suicide Risk

• Primary care signal: Systematic-review evidence supports depression screening in primary care, with lower depression prevalence at 6 months and better symptom improvement in screened patients.
• Suicide screening evidence gap: Suicide-risk screening has not shown clear outcome benefit, and the evidence base is strikingly sparse, with only one included study assessing suicidality outcomes.
• PHQ test performance: PHQ-9 showed roughly 85% sensitivity and 85% specificity, while PHQ-2 was more sensitive but far less specific, a tradeoff that matters when ED resources hinge on a positive screen.
• Suicidality tool limits: Available suicide-screen instruments reported sensitivity above 80%, but the underlying data were tiny and not reproducible, so bedside confidence should stay modest. We get into why that matters in the episode.
• Screening harms uncertainty: Direct evidence of harm from screening was minimal, but downstream harms may be real, including resource use and possible insurance or financial consequences after documented suicidality.

What Positive Screens Mean in the ED

• Screen positive next step: A positive depression or suicidality screen is not a disposition tool; it is a prompt to slow down, assess mental state directly, and clarify actual risk.
• Treatment benefit distinction: Psychotherapy and antidepressants improved depression outcomes, but no comparable signal showed reduction in suicidality, an important distinction when counseling patients and teams.
• SSRI harm signal: Psychotherapy did not show increased harm, while second-generation SSRIs carried a reported 53% relative increase in suicide-attempt risk in one study.
• ED evidence blind spot: Only one study addressed the emergency department population, so importing primary-care screening recommendations into the ED rests on very limited direct evidence.
• Equity limitations: The literature was notably thin in lower-income and minority populations, despite higher burden and different access patterns that may change how screening performs in practice. We cover the practical implications on the show.